Urinary markers for fetal growth restriction: the role of gaseous vasoactive molecules.

Urinary markers for fetal growth restriction: the role of gaseous vasoactive molecules. - Urinary markers and fetal growth restricton

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43012

Enrollment

Registered

2017-02-20

Start date

2017-02-14

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal growth restriction fetal growth retardation

Interventions

fetal growth restriction

gaseous

marker

urine

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Fetal growth restriction hypertension

Exclusion criteria

Exclusion criteria: o Congenital anomalies o being unable to understand the study information either caused by language differences or low IQ o Ruptured membranes o Diabetes Mellitus (defined as use of insulin) o Auto-immune disease o Renal disease o Seropositive for HIV o HELLP o Multiple pregnancy

Design outcomes

Primary

Measure	Time frame
Urinary metabolites and metabolites in blood related to composite neonatal consisting of fetal weight, length, matched for gestational age.	—

Secondary

Measure	Time frame
Placental histology, Doppler abnormalities, mode of delivery, APGAR scores and admission to NICU/ward and the relation of the urinary metabolites to the measurements of these molecules in maternal and fetal blood (umbilical cord blood).	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)